Clinical trial with 2% sodium cromoglycate (Opticrom) in vernal keratoconjunctivitis.
AUTOR(ES)
El Hennawi, M
RESUMO
An open assessment study was carried out during the summer of 1972 in which 2% sodium cromoglycate eyedrops were evaluated in the treatment of patients with vernal keratoconjunctivitis. A highly significant number of patients found the eyedrops effective, while a marked improvement was recorded in mild and moderate cases; in severe cases or in acute exacerbations additional steroid therapy was recommended. Sodium cromoglycate eyedrops were found to be as effective as Decadron and superior to Antistin-Privine. Furthermore SCG eyedrops could replace or reduce local steroid therapy in vernal keratoconjuntivitis and so avert the possible rise in ocular tension caused by steroids.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1043743Documentos Relacionados
- A double blind placebo controlled group comparative study of ophthalmic sodium cromoglycate and nedocromil sodium in the treatment of vernal keratoconjunctivitis.
- Vernal keratoconjunctivitis in an Israeli group of patients and its treatment with sodium cromoglycate.
- Collagen types I and III in giant papillae of vernal keratoconjunctivitis.
- Alterações topográficas da córnea em pacientes com cérato-conjuntivite vernal.
- Clinical features and diagnosis of adult atopic keratoconjunctivitis and the effect of treatment with sodium cromoglycate.
